Phase 1 Study of XAF5 Gel Applied to Skin of Healthy Volunteers

NCT01723241 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: XAF5, concentration A
DRUG: XAF5, concentration B
DRUG: XAF5, concentration C
DRUG: Placebo

Sponsor

Topokine Therapeutics, Inc.